首页> 美国卫生研究院文献>Cardiovascular Diseases >Hypertrophic Obstructive Cardiomyopathy: Hemodynamic Improvement with Intravenous Verapamil
【2h】

Hypertrophic Obstructive Cardiomyopathy: Hemodynamic Improvement with Intravenous Verapamil

机译:肥厚性梗阻性心肌病:静脉使用维拉帕米改善血流动力学

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report the reduction in left ventricular outflow tract gradient following the intravenous administration of verapamil to two pediatric patients with hypertrophic obstructive cardiomyopathy. Traditional therapy with beta adrenergic antagonists was relatively contraindicated in both patients. In a 15-year-old patient, the left ventricular outflow tract gradient decreased from 160 torr, at rest, to 45 torr during the verapamil infusion. In a 3-year-old boy, there was a reduction in the left ventricular outflow tract gradient from 60 torr, under basal conditions, to 10 torr during the intravenous verapamil infusion. We believe that verapamil may be effective in reducing the left ventricular outflow tract gradient in some pediatric patients with hypertrophic obstructive cardiomyopathy and may be useful in treating selected patients with this disorder.
机译:我们报告了维拉帕米静脉注射给两名小儿肥厚性梗阻性心肌病患者后左心室流出道梯度的减少。两名患者均相对禁忌使用β-肾上腺素能拮抗剂的传统疗法。在一名15岁患者中,维拉帕米输注期间左心室流出道梯度从静止时的160托降低到45托。在一个3岁男孩中,在静脉注射维拉帕米期间,左心室流出道的梯度从基础条件下的60托降低到10托。我们相信维拉帕米在某些肥厚性梗阻性心肌病小儿患者中可能有效降低左心室流出道梯度,并且可能对治疗该疾病的特定患者有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号